Table 2.
Clinical characteristics of included pediatric patients with congenital heart disease
| Patient | Age (years) | Sex | Primary diagnosis | Indication for CMR |
|---|---|---|---|---|
| 1 | 9 | w | IAA, LVOTO, VSD, ASD | Evaluation of graft stenosis after Yasui procedure |
| 2 | 6 | m | TOF with PA, MAPCAs | Follow up after TOF repair (progressive right ventricular remodeling) |
| 3 | 9 | w | TOF, MAPCAs | Regular follow up after TOF repair |
| 4 | 9 | m | HLHS with AA, AVSD | Follow-up after Fontan procedure (Hypoxemia episodes) |
| 5 | 4 | m | TA, restrictive BVF, PVS, ASD | Evaluation before Fontan procedure |
| 6 | 2 | m | HLHC with MS and AS, AAH | Evaluation before Fontan procedure |
| 7 | 6 | m | TOF with PA | Follow up after TOF repair (decreasing physical capacity) |
| 8 | 8 | m | TOF | Follow up after TOF repair (low physical capacity) |
| 9 | 9 months | w | DORV, PS, VSD | Progression of heart failure |
| 10 | 5 | m | TOF with PA, MAPCA | Evaluation after TOF repair and before surgery |
| 11 | 2 | w | DILV, DOLV, PA, VSD | Evaluation before Fontan procedure |
| 12 | 2 | m | TOF, ASD | Follow up after TOF repair (decreasing physical capacity) |
| 13 | 5 | m | HLHS | Evaluation before Fontan procedure |
| 14 | 5 | m | TOF, VSD | Follow up after TOF repair (moderate physical capacity) |
| 15 | 7 | m | Bicuspid aortic valve, AI | Critical AI |
| 16 | 4 | w | HLHS | Evaluation before Fontan procedure |
| 17 | 4 | m | DORV, VSD, ASD | Regular follow up after surgery/intervention |
| 18 | 5 | m | DILV, L-TGA, PS | Regular follow up after Fontan procedure |
| 19 | 2 | w | TA | Evaluation before Fontan procedure |
| 20 | 5 | m | HLHS (MA, AA), MAPCA | Evaluation before Fontan procedure |
| 21 | 5 | w | Suspected scimitar syndrome | Confirmation of PAPVC |
| 22 | 2 | w | HLHS (MA, AA), ASD | Evaluation before Fontan procedure |
| 23 | 4 | w | PA, MAPCAs | Evaluation before Fontan procedure |
| 24 | 3 | m | Unbalanced AVSD, ISTA | Evaluation before Fontan procedure |
| 25 | 2 | w | HLHS, VSD, ISTA | Evaluation before Fontan procedure |
| 26 | 6 | m | TOF, MAPCAs | Evaluation after TOF repair and before intervention |
| 27 | 4 | m | TAC, TS, VSD, ASD | Evaluation before Fontan procedure |
| 28 | 7 | m | Right atrial isomerism, AVSD, TAPVC, D-TGA | Regular follow up after Fontan procedure |
| 29 | 3 | w | DILV, L-TGA, ASD, ISTA | Evaluation before Fontan procedure |
| 30 | 5 | w | PA, VSD, ASD | Evaluation before Fontan procedure |
| 31 | 2 | w | TA, VSD, restrictive BVF, PVS | Evaluation before Fontan procedure |
| 32 | 4 | w | ASD, suspected PAPVC | Confirmation of diagnosis |
| 33 | 4 | w | Ebstein’s anomaly, PFO | Progression of heart failure |
| 34 | 4 | m | PA, VSD, ASD | Follow up after graft exchange |
| 35 | 2 | m | DORV, L-TGA, VSD, PFO | Evaluation before surgery (hypoxemia episodes) |
| 36 | 1 | w | Sinus venosus ASD, suspected PAPVC | Confirmation of diagnosis |
AAH aortic arch hypoplasia, AI aortic insufficiency, AS aortic stenosis, ASD atrial septal defect, AVSD atrioventricular septal defect, BVF bulboventricular foramen, DILV double inlet left ventricle, DOLV double outlet left ventricle, DORV double outlet right ventricle, D-TGA dextro-transposition of the great arteries, HLHC hypoplastic left heart complex, HLHS hypoplastic left heart syndrome, IAA interrupted aortic arch, ISTA aortic isthmus stenosis, L-TGA levo-transposition of the great arteries, LVOTO left ventricular outflow tract obstruction, MAPCA main aortopulmonary collateral artery, MS mitral stenosis, PA pulmonary atresia, PAPVC partial anomalous pulmonary venous connection, PFO patent foramen ovale, PS pulmonary stenosis, PVS pulmonary valve stenosis, TA tricuspid atresia, TAC truncus arteriosus communis, TAPVC total anomalous pulmonary venous connection, TOF tetralogy of fallot, TS tricuspid stenosis, VSD ventricular septal defect